Skip to main content
. 2020 Sep 21;64(10):e00056-20. doi: 10.1128/AAC.00056-20

FIG 2.

FIG 2

Dose-dependent inhibition of the replication of indicated HCMV strains by posaconazole. Plaque reduction assays were performed in HFFs infected with the indicated HCMV strains and treated with different doses (from 0.1 to 25 μM) of PCZ. Data are means ± SD from 3 independent experiments carried out in duplicate.